Uni-Bio Science Group (the Company) is listed on the Main Board of Stock Exchange (Stock Code: 0690). The Company is involved in pharmaceutical industry which has great market potential in developing revolutionary solutions for the improvement of human health.

Uni-Bio Science is developing next generation medicines from therapeutic peptides in creating long-acting compounds based on the platform of recombinant DNA technologies. The core business of the Company is the development and sales of medical health products. There are two subsidiary enterprises within the Group; Beijing Gene Tech Pharm Company Limited which is a GMP certificated plant specialized in manufacture of chemical and bio-medical medicines. The other subsidiary Dongguan Tai Li Biotech Company Limited which us specialized in the research and development of chemical and biomedical medicines. The scientific research centre of Dongguan Tai Li is fully equipped with a complete system for the development of genetic engineered products with pilot plant test base which is in line with GMP requirements.The third subsidiary Shenzhen Watsin Genetech Company Limited which is a GMP certificated plant specialized in manufacture of biomedical medicine.